peptides for liver health FAQ

Add, don't switch. NAC operates downstream (glutathione replenishment); peptides work upstream (cytokine suppression). The mechanisms are complementary, not redundant. Research from the Institute of Bioregulation tested combination therapy: patients on both Thymalin and NAC showed 19% greater ALT reduction than either intervention alone. NAC handles existing oxidative damage; peptides reduce the inflammatory signaling generating new damage. Run them concurrently through the 10–12 week protocol, then reassess enzyme levels to determine which to continue long-term.

Use peptides as a 10–12 week intervention to normalize enzymes and reduce inflammation, then transition to maintenance with dietary structure and targeted supplementation. The peptide phase breaks the inflammatory cycle; maintenance prevents recurrence. Post-protocol: continue high protein intake (1.6g/kg minimum), eliminate seed oils and fructose, supplement with NAC 600mg daily, and monitor enzymes every 12 weeks. If ALT creeps back above 40 U/L, run another 6-week peptide course. Peptides aren't meant to be indefinite. They reset the system; dietary discipline maintains it.

Reassess dietary inflammatory load and consider switching peptide class. Non-response by week 8 suggests either inadequate dosing frequency, continued high inflammatory stimulus from diet, or a mechanism mismatch. Thymic peptides work through immune modulation; if the primary driver is oxidative stress rather than cytokine-mediated inflammation, epithalamic peptides or liver-specific sequences may produce better results. Baseline inflammatory markers (CRP, IL-6) help differentiate: if CRP remains elevated despite peptide use, immune dysregulation is still active and requires addressing systemic triggers.

Do not self-prescribe peptides for elevated ALT or AST without identifying the underlying cause. Elevated transaminases can indicate viral hepatitis, autoimmune hepatitis, drug-induced liver injury, or biliary obstruction. Conditions where peptide use is inappropriate or contraindicated. Order a comprehensive metabolic panel, viral hepatitis serology, and abdominal ultrasound first. If the cause is confirmed as non-alcoholic fatty liver disease (NAFLD) or alcohol-related liver damage without active inflammation, peptides like BPC-157 may have a supportive role alongside dietary modification and abstinence from hepatotoxins.

Combining BPC-157 with TB-500 is common in research settings because their mechanisms are non-overlapping. One targets vascular and inflammatory pathways, the other targets cytoskeletal repair. However, there are no published studies on multi-peptide liver protocols in humans. Do not mix peptides in the same syringe unless you have verified chemical compatibility data. Inject each peptide separately, ideally at different sites (abdomen for BPC-157, deltoid or thigh for TB-500). Monitor liver enzymes monthly during combined protocols to detect any unexpected hepatotoxicity.

Peptides are not pharmaceutical drugs with predictable dose-response curves in human liver disease. If ALT and AST remain elevated after 8 weeks of consistent peptide use at research-derived doses, the underlying pathology may require medical intervention beyond peptide support. Re-evaluate with your prescribing physician. You may need fibroscan imaging to assess fibrosis stage, or antiviral therapy if chronic hepatitis is present. Peptides support cellular repair mechanisms, but they cannot reverse advanced cirrhosis or halt progressive autoimmune liver disease without concomitant medical management.

Discard it immediately. Properly reconstituted lyophilised peptides should be crystal-clear. Cloudiness indicates protein aggregation, contamination, or improper lyophilisation during manufacturing. Aggregated proteins cannot bind to their target receptors and may trigger immune responses. Store unreconstituted vials at −20°C and reconstitute only with sterile bacteriostatic water (0.9% benzyl alcohol). Inject bacteriostatic water slowly down the vial wall, never directly onto the peptide cake, and gently swirl. Do not shake. Shaking denatures peptide bonds.